DBS在精神疾病治疗领域的研究进展
Research Progress of DBS in the Treatment of Mental Illness
DOI: 10.12677/ACM.2023.13102216, PDF,   
作者: 赵 聪, 杨 帅, 胡红星*：新疆医科大学第一附属医院心理医学中心，新疆 乌鲁木齐
关键词: 深脑刺激；精神疾病；治疗；Deep Brain Stimulation； Mental Illness； Treatment
摘要: 焦虑障碍、抑郁症、强迫症、酒精使用障碍是常见的精神障碍，目前的治疗手段主要以药物治疗和心理干预为主。近年来对物理治疗也愈加重视。DBS (Deep Brain Stimulation, DBS)作为一种新的物理治疗手段，除了在帕金森等神经系统疾病的治疗中取得明显成效外，对精神疾病的治疗前景也非常广阔，本文对用DBS治疗以上4种疾病的研究进展进行综述，分析该技术对这4种精神疾病治疗的优越性与局限性，探索未来发展方向，为继续推动该技术的发展并以期将来大规模应用于临床提供参考。
Abstract: Anxiety disorders, depression, obsessive-compulsive disorder, and alcohol use disorder are com-mon mental disorders. The current treatment methods are mainly drug therapy and psychological intervention. In recent years, physical therapy has gradually become a synergistic means or alter-native to drug therapy. As a new treatment method, DBS (Deep Brain Stimulation, DBS) has not only achieved remarkable results in the treatment of neurological diseases such as Parkinson’s, but also has a very broad prospect in the treatment of mental diseases. This paper summarizes the research progress, analyzes the advantages and limitations of this technology in the treatment of these 4 mental diseases, explores the future development direction, and provides a reference for continu-ing to promote the development of this technology and its large-scale clinical application in the fu-ture.
文章引用：赵聪, 杨帅, 胡红星. DBS在精神疾病治疗领域的研究进展[J]. 临床医学进展, 2023, 13(10): 15858-15863. https://doi.org/10.12677/ACM.2023.13102216

参考文献

[1] 沈郁邨. 精神病学[M]. 第6版. 北京: 人民卫生出版社, 2018.
[2] Huang, Y.Q., et al. (2019) Prevalence of Men-tal Disorders in China: A Cross-Sectional Epidemiological Study. The Lancet Psychiatry, 6, 211-224. [Google Scholar] [CrossRef] 
[3] Luyten, L. (2020) The Bed Nucleus of the Stria Terminalis: Translational Deep Brain Stimulation to Reduce Anxiety. The Neuroscientist, 26, 278-284. [Google Scholar] [CrossRef] [PubMed]
[4] Freire, R.C., Cabrera-Abreu, C. and Milev, R. (2020) Neurostim-ulation in Anxiety Disorder, Post-Traumatic Stress Disorder, and Obsessive-Compulsive Disorder. In: Kim, Y.K., Ed., Anxiety Disorders, Springer, Singapore, 331-346. [Google Scholar] [CrossRef] [PubMed]
[5] Sarno, M., et al. (2019) Revisiting Eligibility for Deep Brain Stimulation: Do Preoperative Mood Symptoms Predict Outcomes in Parkinson’s Disease Patients? Parkinsonism & Re-lated Disorders, 63, 131-136. [Google Scholar] [CrossRef] [PubMed]
[6] Mokhtari Hashtjini, M., et al. (2018) Aqueous Extract of Saf-fron Administration Along with Amygdala Deep Brain Stimulation Promoted Alleviation of Symptoms in Post-Traumatic Stress Disorder (PTSD) in Rats. Avicenna Journal of Phytomedicine, 8, 358-369.
[7] Luyck, K., Scheyltjens, I., Nut-tin, B., Arckens, L. and Luyten, L. (2020) c-Fos Expression following Context Conditioning and Deep Brain Stimulation in the Bed Nucleus of the Stria Terminalis in Rats. Scientific Reports, 10, Article No. 20529. [Google Scholar] [CrossRef] [PubMed]
[8] Smith, E.E., et al. (2020) Prefrontal Delta Oscillations during Deep Brain Stimulation Predict Treatment Success in Patients with Obsessive-Compulsive Disorder. Brain Stimulation, 13, 259-261. [Google Scholar] [CrossRef] [PubMed]
[9] Graat, I., et al. (2021) Long-Term Outcome of Deep Brain Stimulation of the Ventral Part of the Anterior Limb of the Internal Capsule in a Cohort of 50 Patients with Treat-ment-Refractory Obsessive-Compulsive Disorder. Biological Psychiatry, 90, 714-720. [Google Scholar] [CrossRef] [PubMed]
[10] Naesström, M., Hariz, M., Strömsten, L., Bodlund, O. and Blomstedt, P. (2021) Deep Brain Stimulation in the Bed Nucleus of Stria Terminalis in Obsessive-Compulsive Disor-der-1-Year Follow-Up. World Neurosurgery, 149, e794-e802. [Google Scholar] [CrossRef] [PubMed]
[11] Rappel, P., et al. (2018) Subthalamic Theta Activity: A Novel Human Subcortical Biomarker for Obsessive Compulsive Disorder. Translational Psychiatry, 8, Article No. 118. [Google Scholar] [CrossRef] [PubMed]
[12] Youssef, N.A., et al. (2021) Characteristics of Patients Who Had Deep Brain Stimulation for Treatment-Resistant Depression from among 116, 890 Inpatients with Major Depressive Disorder. American Academy of Clinical Psychiatrists, 33, 251-257. [Google Scholar] [CrossRef] [PubMed]
[13] Ramasubbu, R., et al. (2021) Personality Changes with Subcallosal Cingu-late Deep Brain Stimulation in Patients with Treatment-Resistant Depression. Journal of Psychiatry & Neuroscience, 46, E490-E499. [Google Scholar] [CrossRef] [PubMed]
[14] Scangos, K.W., et al. (2021) State-Dependent Responses to Intracranial Brain Stimulation in a Patient with Depression. Nature Medicine, 27, 229-231. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, Z., et al. (2021) Case Report: Lateral Habenula Deep Brain Stimulation for Treatment-Resistant Depression. Frontiers in Psychiatry, 11, Article 616501. [Google Scholar] [CrossRef] [PubMed]
[16] Mahoney, J.J., Haut, M.W., Hodder, S.L., Zheng, W., Lander, L.R., Berry, J.H., Farmer, D.L., Marton, J.L., Ranjan, M., Brandmeir, N.J., Finomore, V.S., Hensley, J.L., Aklin, W.M., Wang, G.J., Tomasi, D., Shokri-Kojori, E. and Rezai, A.R. (2021) Deep Brain Stimulation of the Nucleus Accum-bens/Ventral Capsule for Severe and Intractable Opioid and Benzodiazepine Use Disorder. Experimental and Clinical Psychopharmacology, 29, 210-215. [Google Scholar] [CrossRef] [PubMed]
[17] Zhu, R., Zhang, Y., Wang, T., Wei, H., Zhang, C., Li, D., Zhan, S and Sun, B. (2020) Deep Brain Stimulation of Nucleus Accumbens with Anterior Capsulotomy for Drug Addiction: A Case Report. Stereotactic and Functional Neurosurgery, 98, 345-349. [Google Scholar] [CrossRef] [PubMed]
[18] Naish, K.R., Vedelago, L., MacKillop, J. and Amlung, M. (2018) Effects of Neuromodulation on Cognitive Performance in In-dividuals Exhibiting Addictive Behaviour: A Systematic Review Protocol. Systematic Reviews, 7, Article No. 90. [Google Scholar] [CrossRef] [PubMed]
[19] Navarro, P.A., Paranhos, T., Lovo, E., De Oliveira-Souza, R., Gorgulho, A.A., De Salles, A. and López, W.O.C. (2021) Safety and Feasibility of Nucleus Accumbens Surgery for Drug Addiction: A Systematic Review. Neuromodulation, 25, 171-184. [Google Scholar] [CrossRef] [PubMed]
[20] Rezai, A.R., Mahoney, J.J., Ranjan, M., Haut, M.W., Zheng, W., Lander, L.R., Berry, J.H., Farmer, D.L., Marton, J.L., Tirumalai, P., Mears, A., Thompson-Lake, D.G.Y., Finomore, V.S., D’Haese, P.F., Aklin, W.M., George, D.T., Corrigan, J.D. and Hodder, S.L. (2023) Safety and Feasibility Clinical Trial of Nucleus Accumbens Deep Brain Stimulation for Treatment-Refractory Opioid Use Disorder. Journal of Neurosur-gery, 1-9. [Google Scholar] [CrossRef] 
[21] Bach, P., Luderer, M., Müller, U.J., Jakobs, M., Baldermann, J.C., Voges, J., Kiening, K., Lux, A., Visser-Vandewalle, V., DeBraSTRA Study Group, Bogerts, B., Kuhn, J. and Mann, K. (2023) Deep Brain Stimulation of the Nucleus Accumbens in Treatment-Resistant Alcoholuse Disorder: A Double-Blind Randomized Controlled Multi-Center Trial. Translational Psychiatry, 13, Article No. 49. [Google Scholar] [CrossRef] [PubMed]
[22] Davidson, B., Giacobbe, P., George, T.P., Nestor, S.M., Rabin, J.S., Goubran, M., Nyman, A.J., Baskaran, A., Meng, Y., Pople, C.B., Graham, S.J., Tam, F., Hamani, C. and Lipsman, N. (2022) Deep Brain Stimulation of the Nucleus Accumbens in the Treatment of Severe Alcohol Use Disorder: A Phase I Pilot Trial. Molecular Psychiatry, 27, 3992-4000. [Google Scholar] [CrossRef] [PubMed]

为你推荐